# CYSTEINE HYDROCHLORIDE

NDC: 0338-9645
Generic name: cysteine hydrochloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220429

FDA application: NDA212535

## Active ingredients

- CYSTEINE HYDROCHLORIDE: 34.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9645"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9645
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbf70fc3-14b3-4c17-8de8-acba1e12ac95